Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bulk water protons in biological tissues refer to the hydrogen nuclei (1H) within mobile water molecules, which serve as the primary signal source for Magnetic Resonance Imaging (MRI) [1: https://www.ncbi.nlm.nih.gov/books/NBK564320/]. These protons are not considered a therapeutic target in the traditional sense (e.g., a receptor or enzyme), but they are the fundamental physical substrate for diagnostic imaging and the functional target for MRI contrast agents [3: https://pubmed.ncbi.nlm.nih.gov/11540305/]. The relaxation properties of these protons, known as T1 and T2, are highly sensitive to the local biochemical environment, allowing for the visualization of anatomical structures and pathological changes such as edema, inflammation, and malignancy [1]. Gadolinium-based contrast agents (GBCAs) interact with bulk water protons through paramagnetic relaxation enhancement, which shortens relaxation times and increases signal intensity to improve diagnostic accuracy [2: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-evaluates-identified-safety-issue-adverse-effects-gadolinium]. While these protons are ubiquitous and essential for life as part of the biological solvent, their manipulation via external magnetic fields and contrast media is a cornerstone of modern radiology [1][3]. Safety considerations in this context primarily involve the potential for gadolinium toxicity, such as Nephrogenic Systemic Fibrosis, and the physical effects of radiofrequency energy on tissue [2]. Consequently, bulk water protons remain a central focus of radiological research and diagnostic medicine.
Paramagnetic relaxation enhancement (PRE) and chemical exchange saturation transfer (CEST) are the primary mechanisms. Contrast agents containing paramagnetic ions (e.g., Gadolinium) interact with bulk water protons to shorten their longitudinal (T1) and transverse (T2) relaxation times, thereby enhancing signal intensity in MRI [1][2].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bulk water protons in biological tissues (1H).